Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · Real-Time Price · USD

28.19

+1.53 (5.74%)

At close: May 1, 2026, 4:00 PM EDT

27.75

-0.44 (-1.56%)

After-hours: May 1, 2026, 5:06 PM EDT

Forte Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	690	353	145	30	21	32
Market Cap Growth	1344.12%	143.19%	386.36%	42.16%	-33.49%	-93.24%
Enterprise Value	613.08	276.14	86.83	-7.27	-20.1	-10.47
Last Close Price	28.19	27.27	22.71	20.54	25.00	53.50
PE Ratio	-	-5.79	-1.87	-0.82	-1.25	-1.38
PB Ratio	8.24	5.79	2.77	0.85	0.54	0.76
P/TBV Ratio	6.79	6.58	1.26	0.74	0.45	0.72
P/FCF Ratio	-	-6.92	-4.72	-1.04	-2.57	-1.89
P/OCF Ratio	-	-6.94	-4.72	-1.04	-2.57	-1.89
EV/EBITDA Ratio	-	-3.91	-2.37	0.22	1.45	0.49
EV/EBIT Ratio	-	-3.91	-2.37	0.22	1.45	0.49
EV/FCF Ratio	-	-5.41	-2.82	0.25	2.46	0.63
Net Debt / Equity Ratio	-1.26	-1.26	-1.11	-1.05	-1.06	-1.01
Net Debt / EBITDA Ratio	1.09	1.09	1.60	1.14	2.96	1.96
Net Debt / FCF Ratio	1.51	1.51	1.90	1.29	5.02	2.52
Quick Ratio	3.71	3.71	6.43	10.13	12.93	23.92
Current Ratio	3.88	3.88	6.76	10.45	13.06	24.19
Return on Equity (ROE)	-121.89%	-122.28%	-80.82%	-84.92%	-34.54%	-43.19%
Return on Assets (ROA)	-99.37%	-99.39%	-72.81%	-80.24%	-32.58%	-41.10%
Return on Invested Capital (ROIC)	656.41%	656.53%	951.20%	1587.39%	1000.43%	15292.50%
Return on Capital Employed (ROCE)	-123.41%	-123.41%	-83.38%	-87.64%	-34.58%	-42.75%
Earnings Yield	-10.05%	-17.27%	-53.59%	-121.32%	-80.00%	-72.43%
FCF Yield	-7.39%	-14.44%	-21.20%	-96.45%	-38.98%	-52.82%
Buyback Yield / Dilution	-404.74%	-404.74%	-130.90%	-81.61%	-24.45%	-89.81%
Total Shareholder Return	-404.74%	-404.74%	-130.90%	-81.61%	-24.45%	-89.81%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q